시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 심장 AI 모니터링 및 진단 시장 보고서(2025년)
Cardiac AI Monitoring And Diagnostics Global Market Report 2025
상품코드 : 1824603
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,666,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,635,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,605,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

심장 AI 모니터링 및 진단 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 26.4%를 나타내 54억 8,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 웨어러블 디바이스와 IoT 디바이스의 확대, 원격 의료 및 원격 모니터링 채택 확대, 빅데이터 분석과 예측 모델링의 통합, 환자 중심의 케어와 원격 환자 참여의 중시, 헬스케어 인프라 개발에 기인합니다. 예측 기간의 주요 동향으로는 웨어러블 디바이스와 AI 통합, 개별화된 위험 평가 및 치료 계획, 심혈관 이벤트 예측 분석, 멀티모달 데이터 소스 통합, 상호 운용성 및 데이터 통합 표준 등이 있습니다.

향후 5년간의 성장률 26.4%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 상승은 핀란드와 에스토니아에서 조달한 인공지능(AI) 탑재 심전도(ECG) 분석기와 웨어러블 부정맥 검출기의 비용을 밀어 올려 심혈관 질환 관리 비용을 악화시킴으로써 미국의 심장병학에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

심혈관 질환(CVDs)의 유병률 증가는 심장 AI 모니터링 및 진단 시장 성장을 가속할 것으로 예측됩니다. CVD는 뇌혈관 질환, 관상동맥성 심장 질환, 류마티스성 심장 질환 등 심장 및 혈관에 영향을 미치는 다양한 질환을 포함합니다. 심장 AI 모니터링 및 진단은 심혈관 질환의 조기 진단, 위험 평가, 개인화 치료를 촉진하고 환자 결과를 개선합니다. 예를 들어, 2024년 9월 영국을 거점으로 하는 심장혈관연구 자선단체인 British Heart Foundation의 데이터에 따르면 영국에서는 약 760만명이 심장·순환기계 질환을 앓았으며, 그중 남성은 약 400만명, 여성은 약 360만명이 앓았습니다. 이러한 질병은 영국의 전체 사망의 약 27%를 차지하며, 연간 17만명 이상, 하루에 약 480명, 3분에 1명이 사망하고 있습니다. 그 결과, 심혈관 질환의 이환율 증가가 심장 AI 모니터링 및 진단 시장 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Cardiac AI monitoring and diagnostics involve the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This utilizes advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

The main categories of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics encompass methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products in this category include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others. End users of these cardiac AI solutions include hospitals, diagnostic centers, and various healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cardiac AI monitoring and diagnostics research report is one of a series of new reports from The Business Research Company that provides cardiac AI monitoring and diagnostics market statistics, including the cardiac AI monitoring and diagnostics industry's global market size, regional shares, competitors with an cardiac AI monitoring and diagnostics market share, detailed cardiac AI monitoring and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac AI monitoring and diagnostics industry. This cardiac AI monitoring and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac ai monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.71 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 25.6%. The growth in the historic period can be attributed to aging population demographics, rise in remote patient monitoring, increased healthcare expenditure, clinical research and validation studies, focus on preventive healthcare.

The cardiac ai monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $5.48 billion in 2029 at a compound annual growth rate (CAGR) of 26.4%. The growth in the forecast period can be attributed to expansion of wearable and IoT devices, increasing adoption of telemedicine and remote monitoring, integration of big data analytics and predictive modeling, focus on patient-centered care and remote patient engagement, healthcare infrastructure development. Major trends in the forecast period include integration of AI with wearable devices, personalized risk assessment and treatment planning, predictive analytics for cardiovascular events, integration of multimodal data sources, interoperability and data integration standards.

The forecast of 26.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cardiology by driving up the cost of Artificial intelligence(AI)-powered Electrocardiogram(ECG) analyzers and wearable arrhythmia detectors sourced from Finland and Estonia, exacerbating cardiovascular disease management costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cardiovascular diseases (CVDs) is expected to drive growth in the cardiac AI monitoring and diagnostics market. CVDs encompass a range of conditions affecting the heart and blood vessels, including cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Cardiac AI monitoring and diagnostics facilitate early diagnosis, risk assessment, and personalized treatment for cardiovascular conditions, improving patient outcomes. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women affected. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or about 480 deaths per day, equivalent to one death every three minutes. Consequently, the increasing incidence of cardiovascular diseases is fueling growth in the cardiac AI monitoring and diagnostics market.

Leading companies operating in the cardiac AI monitoring and diagnostics market are directing their efforts towards the development of technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their position in the market. Artificial intelligence-based implantable cardiac monitors represent a groundbreaking innovation in cardiovascular healthcare, offering continuous and accurate monitoring of cardiac function. For example, in May 2023, Biotronik, a renowned cardiovascular biomedical research and technology company based in Germany, announced the FDA approval of its BIOMONITOR IV implantable cardiac monitor (ICM). Equipped with BIOTRONIK's cutting-edge SmartECG algorithm powered by artificial intelligence, the BIOMONITOR IV ICM sets a new standard in cardiac monitoring accuracy. By leveraging advanced algorithms, the SmartECG technology significantly reduces false identifications while maintaining a high detection rate for genuine cardiac episodes. This enhancement in detection accuracy empowers healthcare professionals to make prompt and precise diagnoses, thus optimizing patient care and outcomes. Furthermore, the BIOMONITOR IV ICM distinguishes between different types of cardiac contractions, such as premature ventricular contractions (PVCs) and premature atrial contractions (PACs), further enhancing its diagnostic capabilities and clinical utility.

In January 2022, Koninklijke Philips N.V., a healthcare technology company headquartered in the Netherlands, completed the acquisition of Cardiologs Technologies SAS, a medical technology company based in France, for an undisclosed sum. This strategic move positions Cardiologs to enhance Philips' cardiac monitoring and diagnostics portfolio through the integration of innovative software solutions, electrocardiogram (ECG) analysis, and reporting services. Cardiologs Technologies SAS specializes in optimizing cardiac diagnostics through the utilization of artificial intelligence (AI) and cloud technologies, aligning with Philips' commitment to advancing healthcare through cutting-edge innovations.

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac ai monitoring and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac AI Monitoring And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac ai monitoring and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cardiac ai monitoring and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac ai monitoring and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cardiac AI Monitoring And Diagnostics Market Characteristics

3. Cardiac AI Monitoring And Diagnostics Market Trends And Strategies

4. Cardiac AI Monitoring And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cardiac AI Monitoring And Diagnostics Growth Analysis And Strategic Analysis Framework

6. Cardiac AI Monitoring And Diagnostics Market Segmentation

7. Cardiac AI Monitoring And Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market

9. China Cardiac AI Monitoring And Diagnostics Market

10. India Cardiac AI Monitoring And Diagnostics Market

11. Japan Cardiac AI Monitoring And Diagnostics Market

12. Australia Cardiac AI Monitoring And Diagnostics Market

13. Indonesia Cardiac AI Monitoring And Diagnostics Market

14. South Korea Cardiac AI Monitoring And Diagnostics Market

15. Western Europe Cardiac AI Monitoring And Diagnostics Market

16. UK Cardiac AI Monitoring And Diagnostics Market

17. Germany Cardiac AI Monitoring And Diagnostics Market

18. France Cardiac AI Monitoring And Diagnostics Market

19. Italy Cardiac AI Monitoring And Diagnostics Market

20. Spain Cardiac AI Monitoring And Diagnostics Market

21. Eastern Europe Cardiac AI Monitoring And Diagnostics Market

22. Russia Cardiac AI Monitoring And Diagnostics Market

23. North America Cardiac AI Monitoring And Diagnostics Market

24. USA Cardiac AI Monitoring And Diagnostics Market

25. Canada Cardiac AI Monitoring And Diagnostics Market

26. South America Cardiac AI Monitoring And Diagnostics Market

27. Brazil Cardiac AI Monitoring And Diagnostics Market

28. Middle East Cardiac AI Monitoring And Diagnostics Market

29. Africa Cardiac AI Monitoring And Diagnostics Market

30. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape And Company Profiles

31. Cardiac AI Monitoring And Diagnostics Market Other Major And Innovative Companies

32. Global Cardiac AI Monitoring And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market

34. Recent Developments In The Cardiac AI Monitoring And Diagnostics Market

35. Cardiac AI Monitoring And Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기